1 min read

Five-minute Q & A: Sg2 data for revenue growth planning

Courtney Yule : Published November 10, 2022 Updated November 24, 2025

MarketEdge

Five-minute Q & A: Sg2 data for revenue growth planning

New trends and change agents are increasingly challenging health systems’ volume and revenue growth. To compete and stay relevant, they must take a more balanced approach to their near-, mid-and long-term growth.

DataGen and Sg2 recently joined forces to host Optimizing strategic planning for revenue growth: DataGen and Sg2 resources. This webinar featured customers' experiences using Sg2's suite of analytical tools and how, when partnered with DataGen's customized customer service and training, these tools helped their organization optimize its strategic planning for enhanced revenue growth.

We broke down five common questions asked during the session.

1. What disruptors are you keeping an eye on?

We are keeping an eye on four major disruptors: Retail clinics, big tech/digital, VC-backed medical groups and payers as providers.

2. What downstream effects have these disruptors had on inpatient volumes?

Nationally, IP utilization has remained well below pre-pandemic levels through Q2 2022. Through Sg2’s partnership with Strata Decision Technology, we compared adult quarterly volumes from 2019 vs. 2020-2022. Across the country, there is a decline of 10% when you include COVID-19 diagnosis and 14% when you exclude COVID-19 diagnosis.

3. What downstream effects have these disruptors had on outpatient volumes?

Outpatient volume demonstrates recovery and growth beyond pre-pandemic levels. According to Strata Decision Technology, the adult quarterly volumes, including COVID-19 from 2019 vs. 2020-2022, revealed OP, OP surgery and E&M are all up between 4% and 5%, while ED visits are flat.

4. What are some key 2022 forecast considerations?

Endemic COVID-19
Rising patient acuity
Shift to OP slowing
Expanded care at home capabilities
Record MA enrollment

5. What does today’s winning growth portfolio look like?

Near-term: Drive an optimal patient mix through the existing footprint.
Mid-term: Increase revenue and margin capture for patients you serve.
Long-term: Evolve and expand the footprint to win more patients.

Struggling to get a comprehensive view of your market, competitive position and growth opportunities to guide your strategic planning? Check out how DataGen's partnership with Sg2 can help.